<p>Through a robust DRTB surveillance data collection system the NTLDP has developed policies and programmatic management of drug-resistant TB guidelines, tracking DRTB trends and patterns to detect, investigate and respond to outbreaks. Equally, the development of the national strategic plan 2023-2028, identification of the DRTB ‘hot spots’ to allocate resources, targeted healthcare training, risk communication, community engagement, screening, and tailored patient management. In resource mobilization success has been seen in reduction of catastrophic cost, individualized regimen formulation, innovations (introducing new tools project), spatial analysis for equipment placement, adherence of &gt;95% for all DR TB patients recruited and treatment success rates of 90%. Through all these initiatives, public health impact has been seen increased cure rate from 56% (2019) to 67% (2022), an increased treatment success rate from 77% (2019) to 81% (2022), the reduced death rate from 13% (2019) to 11% (2022) and reduced loss to follow up from 5% to 4%.</p>